Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Knee Osteoarthritis
NCT05825105Phase 2Completed
- Sponsor
- Universidad Nacional de Entre Ríos
- Start
- May 2024
- Primary completion
- Aug 2026
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 2, randomised trial of platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by Universidad Nacional de Entre Ríos. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 48 weeks. Started May 2024; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05825105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05825105.